Palvella Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	999	135	-	-
Enterprise Value	874	215	-	-
Last Close Price	77.88	12.00	-	-
PB Ratio	22.32	2.15	-	-
P/TBV Ratio	23.83	2.15	-	-
Debt / Equity Ratio	0.41	0.19	-2.08	-1.40
Quick Ratio	6.38	7.14	3.11	2.78
Current Ratio	6.49	7.33	3.20	2.86
Return on Equity (ROE)	-301.19%	-59.37%	-	-
Return on Assets (ROA)	-47.54%	-18.39%	-61.63%	-
Return on Capital Employed (ROCE)	-55.90%	-18.50%	-228.80%	-167.90%
Earnings Yield	-3.51%	-12.95%	-	-
Buyback Yield / Dilution	-60.51%	-24.08%	68.63%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q